SCHEMBL17197546

SCHEMBL17197546

c1ccc(-c2ccc(N3c4ccccc4C4(c5ccccc53)c3ccccc3N(c3ccc(-c5ccc6c(c5)oc5ccccc56)cc3)c3ccc(-c5ccccc5)cc34)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
PTGER4 P35408 1/20 0.36
PRKDC P78527 3/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
ATM Q13315 1/20 0.35
AHR P35869 2/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PLA2G2A P14555 4/20 0.34
PLA2G4A P47712 4/20 0.34
HCRTR1 O43613 1/20 0.34
PLA2G10 O15496 1/20 0.31
TTR P02766 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17197550 1.00 MMP12 (0.38) MMP12MMP13PTGER4PRKDCNPC1
SCHEMBL15030760 0.94 MMP12 (0.34) MMP12MMP13PTGER4PRKDCNPC1
SCHEMBL17197547 0.93 PLA2G2A (0.40) MMP12MMP13PTGER4PRKDCNPC1
SCHEMBL17197504 0.88 PDE6D (0.36) PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL13827521 0.88 MMP12 (0.36) MMP12MMP13PTGER4PRKDCNPC1
SCHEMBL15030692 0.88 PLA2G2A (0.36) PRKDCNPC1RAB9AAHRMEN1
SCHEMBL13827271 0.87 PLA2G2A (0.38) PTGER4PRKDCNPC1RAB9AAHR
SCHEMBL17197507 0.87 ALOX5 (0.35) PRKDCMEN1KMT2APLA2G2APLA2G4A
SCHEMBL17197580 0.86 PDE6D (0.37) PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL17197515 0.86 PDE6D (0.37) PRKDCPLA2G2APLA2G4APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10374168-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2019-08-06 US disclosed
EP-3131901-B1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-02-07 EP disclosed
US-20170125701-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-05-04 US disclosed
US-20170125701-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2017-05-04 US disclosed
WO-2015158411-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-10-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170125701-A1 MATERIALS FOR ELECTRONIC DEVICES HCN2, EFNA1, EED MMP12 4544/4885MMP13 4610/4885PTGER4 3975/4885
US-10374168-B2 Materials for electronic devices HCN2, EFNA1, EED MMP12 4544/4885MMP13 4610/4885PTGER4 3975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.